Ahmed Eldib
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Ahmed Eldib has a total of 64 co-authors. Here are the top co-authors by number of shared publications:
Jinsheng Li
OUR United Corporation, Xian, China
4 shared publications- Charlie M. Ma
Department of Radiation Oncology, Fox Chase Cancer Center, 333 Cottman Avenue, Philadelphia, PA 19111, USA, philadelphia, Pennsylvania, 19111, UNITED STATES
3 shared publications - Jianchang Fan
School of Marketing and Logistics Management, Nanjing University of Finance and Economics, Nanjing, China
3 shared publications Robert Price
3 shared publicationsC-M Charlie Ma
Department of Radiation Oncology, Fox Chase Cancer Center, Philadelphia, PA 19111, United States of America
2 shared publications- Chen Ma
The CONVERSATIONALIST club & Department of Dental Digitalization, School of Stomatology, Shandong First Medical University, Jinan, Shandong 250117, China
2 shared publications
Latest Publications
- 11 December 2025
- Published by Elsevier in Radiation Physics and Chemistry
- Vol. 242
Investigation of bolus adjustment in cases of progressive disease
- 11 December 2025
- Published by Elsevier in Radiation Physics and Chemistry
- Vol. 242
Investigation of bolus adjustment in cases of progressive disease
- 21 July 2025
- Published by IOP Publishing in Biomedical Physics & Engineering Express
- Vol. 11 (4) , 045032
Dosimetric investigation of a rotating gamma ray system
Background. Radiosurgery has become an important treatment alternative to surgery for a variety of intracranial lesions. All commercially available systems use convergent beam techniques, but they differ in their treatment delivery methods depending on the machine design and workspace. Purpose. The aim of this work is to investigate a new design for a gamma ray system developed for both intra and extra-cranial stereotactic body radiation therapy (SBRT). Methods. Monte Carlo simulations have been conducted to evaluate rotational radiation delivery using Cobalt-60 gamma beams as compared to linac beams with higher energies. A rotating gamma ray system (RGS), has been modeled using the MCBEAM Monte Carlo code. Treatment plans have been generated utilizing MCPLAN, which is an in-house Monte Carlo treatment planning system. Dosimetric differences between RGS Cobalt-60 beams and Robotic arm linac (RAL) 6 MV beams have been compared in a lung phantom and for previously treated SBRT patients. Results. Results showed that the need for high-energy photon beams decreases with rotational delivery treatments. Cobalt-60 beams could provide a reasonable compromise between beam penetration and penumbra characteristics for lung SBRT applications. The proper combination of available collimator cone sizes and various oblique beam angles allows RGS to shape the isodose lines effectively to match the target volume. The treatment plan quality for RGS has been comparable to that of RAL for both intra- and extra cranial cases. Intensity modulated arcs are feasible with RGS and can add more planning capabilities. Conclusions. The rotating design of the RGS can be of clinical benefit for stereotactic radiation therapy treating cranial cases plus the added ability of treating extra-cranial cases.
- 21 July 2025
- Published by IOP Publishing in Biomedical Physics & Engineering Express
- Vol. 11 (4) , 045032
Dosimetric investigation of a rotating gamma ray system
Background. Radiosurgery has become an important treatment alternative to surgery for a variety of intracranial lesions. All commercially available systems use convergent beam techniques, but they differ in their treatment delivery methods depending on the machine design and workspace. Purpose. The aim of this work is to investigate a new design for a gamma ray system developed for both intra and extra-cranial stereotactic body radiation therapy (SBRT). Methods. Monte Carlo simulations have been conducted to evaluate rotational radiation delivery using Cobalt-60 gamma beams as compared to linac beams with higher energies. A rotating gamma ray system (RGS), has been modeled using the MCBEAM Monte Carlo code. Treatment plans have been generated utilizing MCPLAN, which is an in-house Monte Carlo treatment planning system. Dosimetric differences between RGS Cobalt-60 beams and Robotic arm linac (RAL) 6 MV beams have been compared in a lung phantom and for previously treated SBRT patients. Results. Results showed that the need for high-energy photon beams decreases with rotational delivery treatments. Cobalt-60 beams could provide a reasonable compromise between beam penetration and penumbra characteristics for lung SBRT applications. The proper combination of available collimator cone sizes and various oblique beam angles allows RGS to shape the isodose lines effectively to match the target volume. The treatment plan quality for RGS has been comparable to that of RAL for both intra- and extra cranial cases. Intensity modulated arcs are feasible with RGS and can add more planning capabilities. Conclusions. The rotating design of the RGS can be of clinical benefit for stereotactic radiation therapy treating cranial cases plus the added ability of treating extra-cranial cases.
- 11 September 2024
- Published by IOP Publishing in Biomedical Physics & Engineering Express
- Vol. 10 (6) , 065012
Investigation of the linear accelerator low dose rate mode for pulsed low-dose-rate radiotherapy delivery
Purpose. Pulsed volumetric modulated arc therapy (VMAT) was proposed as an advanced treatment that combines the biological benefits of pulsed low dose rate (PLDR) and the dosimetric benefits of the intensity-modulated beams. In our conventional pulsed VMAT technique, a daily fractional dose of 200 cGy is delivered in 10 arcs with 3 min intervals between the arcs. In this study, we are testing the feasibility of pulsed VMAT that omits the need to split into ten arcs and excludes any beam-off gaps. Methods. The study was conducted using computed tomographic images of 24 patients previously treated at our institution with the conventional PLDR technique. Our newly installed Elekta machine has a low dose rate option on the order of 25 MU min−1. PLDR requires an effective dose rate of 6.7 cGy min−1 with attention being paid to the maximum dose received within any point within the target not to exceed 13 cGy min−1. The quality of treatment plans was judged based on dose-volume histograms, isodose distribution, dose conformality to the target, and target dose homogeneity. The dose delivery accuracy was assessed by measurements using the MatriXX Evolution 2D array system. Results. All cases were normalized to cover 95% of the target volume with 100% of the prescription dose. The average conformity index was 1.03 ± 0.08 while the average homogeneity index was 1.05 ± 0.02. The maximum reported dose rate at any point within the target was 10.44 cGy min−1. The mean dose rate for all pulsed VMAT plans was 6.88 ± 0.1 cGy min−1. All cases passed our gamma analysis with an average passing rate of 99.00% ± 0.48%. Conclusion. The study showed the applicability of planning pulsed VMAT using Eclipse and its successful delivery on our Elekta linac. Pulsed VMAT using the machine’s low dose rate mode is more efficient than our previous pulsed VMAT delivery.
- 11 September 2024
- Published by IOP Publishing in Biomedical Physics & Engineering Express
- Vol. 10 (6) , 065012
Investigation of the linear accelerator low dose rate mode for pulsed low-dose-rate radiotherapy delivery
Purpose. Pulsed volumetric modulated arc therapy (VMAT) was proposed as an advanced treatment that combines the biological benefits of pulsed low dose rate (PLDR) and the dosimetric benefits of the intensity-modulated beams. In our conventional pulsed VMAT technique, a daily fractional dose of 200 cGy is delivered in 10 arcs with 3 min intervals between the arcs. In this study, we are testing the feasibility of pulsed VMAT that omits the need to split into ten arcs and excludes any beam-off gaps. Methods. The study was conducted using computed tomographic images of 24 patients previously treated at our institution with the conventional PLDR technique. Our newly installed Elekta machine has a low dose rate option on the order of 25 MU min−1. PLDR requires an effective dose rate of 6.7 cGy min−1 with attention being paid to the maximum dose received within any point within the target not to exceed 13 cGy min−1. The quality of treatment plans was judged based on dose-volume histograms, isodose distribution, dose conformality to the target, and target dose homogeneity. The dose delivery accuracy was assessed by measurements using the MatriXX Evolution 2D array system. Results. All cases were normalized to cover 95% of the target volume with 100% of the prescription dose. The average conformity index was 1.03 ± 0.08 while the average homogeneity index was 1.05 ± 0.02. The maximum reported dose rate at any point within the target was 10.44 cGy min−1. The mean dose rate for all pulsed VMAT plans was 6.88 ± 0.1 cGy min−1. All cases passed our gamma analysis with an average passing rate of 99.00% ± 0.48%. Conclusion. The study showed the applicability of planning pulsed VMAT using Eclipse and its successful delivery on our Elekta linac. Pulsed VMAT using the machine’s low dose rate mode is more efficient than our previous pulsed VMAT delivery.
- 4 September 2023
- Published by Mathews International Publishers in Mathews Journal of Cancer Science
- Vol. 8 (3)
Dosimetric Investigation of Modulation Capabilities of a Novel Rotating Gamma Ray System
- 4 September 2023
- Published by Mathews International Publishers in Mathews Journal of Cancer Science
- Vol. 8 (3)
Dosimetric Investigation of Modulation Capabilities of a Novel Rotating Gamma Ray System
- 21 October 2020
- Published by Springer Nature in Journal of Radiation Oncology
- Vol. 9 (3-4) , 173-184
Dosimetric evaluation of a rotating gamma-ray system for stereotactic body radiation therapy
- 21 October 2020
- Published by Springer Nature in Journal of Radiation Oncology
- Vol. 9 (3-4) , 173-184
Dosimetric evaluation of a rotating gamma-ray system for stereotactic body radiation therapy
- 18 May 2017
- Published by IOP Publishing in Biomedical Physics & Engineering Express
- Vol. 3 (3) , 035013
Investigating the dosimetric benefits of modulated electron radiation therapy (MERT) for partial scalp patients
Purpose. Modulated electron radiation therapy (MERT) can offer advantages over conventional radiotherapy for the treatment of superficial targets. MERT can effectively achieve conformal dose distributions to shallow tumors while sparing distal critical structures. The aim of the present study is to investigate the potential dosimetric advantage of scalp radiation therapy using MERT as compared with the conventional electron and advanced photon techniques. Methods. Treatment planning was performed for multiple electron beams using an in-house developed Monte Carlo-based inverse planning system, MCPLAN. Treatment optimization was performed based on an equivalent uniform dose objective function and a gradient search algorithm. Treatment planning was based on delivery using a prototype multileaf collimator that has been investigated for MERT. Results. Five previous scalp patients who were treated with volumetric modulated arc therapy (VMAT) were re-planned using MERT treatment technique. PTV coverage was comparable between MERT and VMAT plans. MERT produced a larger hot spot inside the PTV compared to VMAT. The VMAT plan showed larger volumes enclosed by the 50% and 30% isodose surfaces compared to MERT. The mean brain dose was significantly reduced with MERT (422 cGy) compared to that with VMAT (1032 cGy). Both MERT and VMAT treatment plans met our clinical acceptance criteria for skin dose. Conclusions. MERT was able to adequately cover the planned target volume and decrease the dose to the brain when compared to the VMAT plans. MERT was more efficient in treating some of the scalp cases. MERT was shown to be a promising modality for treating scalp cases and could be beneficial to other superficial tumors with complex shapes.
- 18 May 2017
- Published by IOP Publishing in Biomedical Physics & Engineering Express
- Vol. 3 (3) , 035013
Investigating the dosimetric benefits of modulated electron radiation therapy (MERT) for partial scalp patients
Purpose. Modulated electron radiation therapy (MERT) can offer advantages over conventional radiotherapy for the treatment of superficial targets. MERT can effectively achieve conformal dose distributions to shallow tumors while sparing distal critical structures. The aim of the present study is to investigate the potential dosimetric advantage of scalp radiation therapy using MERT as compared with the conventional electron and advanced photon techniques. Methods. Treatment planning was performed for multiple electron beams using an in-house developed Monte Carlo-based inverse planning system, MCPLAN. Treatment optimization was performed based on an equivalent uniform dose objective function and a gradient search algorithm. Treatment planning was based on delivery using a prototype multileaf collimator that has been investigated for MERT. Results. Five previous scalp patients who were treated with volumetric modulated arc therapy (VMAT) were re-planned using MERT treatment technique. PTV coverage was comparable between MERT and VMAT plans. MERT produced a larger hot spot inside the PTV compared to VMAT. The VMAT plan showed larger volumes enclosed by the 50% and 30% isodose surfaces compared to MERT. The mean brain dose was significantly reduced with MERT (422 cGy) compared to that with VMAT (1032 cGy). Both MERT and VMAT treatment plans met our clinical acceptance criteria for skin dose. Conclusions. MERT was able to adequately cover the planned target volume and decrease the dose to the brain when compared to the VMAT plans. MERT was more efficient in treating some of the scalp cases. MERT was shown to be a promising modality for treating scalp cases and could be beneficial to other superficial tumors with complex shapes.
- 3 February 2014
- Published by IOP Publishing in Physics in Medicine & Biology
- Vol. 59 (4) , 819-836
Investigation of the clinical potential of scattering foil free electron beams
Electron beam therapy has been an important radiation therapy modality for many decades. Studies have been conducted recently for more efficient and advanced delivery of electron beam radiation therapy. X-ray contamination is a common problem that exists with all of the advanced electron beam therapy techniques such as Bolus Electron conformal therapy, segmented electron conformal therapy, and modulated electron arc therapy. X-ray contamination could add some limitations to the advancement and clinical utility of those electron modalities. It was previously shown in the literature that the scattering foil is one of the major accelerator parts contributing to the generation of bremsstrahlung photons. Thus, in this work we investigate the dosimetric characteristics of scattering foil free (SFF) electron beams and the feasibility of using those beams for breast cancer boosts. The SFF electron beams were modeled and simulated using the Monte Carlo method. CT scans of six previously treated breast patients were used for the treatment plan generation utilizing our in-house Monte Carlo-based treatment planning system. Electron boost plans with conventional beams and the SFF beams were generated, respectively, for all patients. A significant reduction of the photon component was observed with the removal of the primary scattering foil for beam energies higher than 12 MeV. Flatness was greatly affected but the difference in flatness between conventional and SFF beams was much reduced for small cone sizes, which were often used clinically for breast boosts. It was found that the SFF electron beams could deliver high-quality dose distributions as conventional electron beams for boost treatments of the breast with an added advantage of a further reduced dose to the lung and the heart.
- 3 February 2014
- Published by IOP Publishing in Physics in Medicine & Biology
- Vol. 59 (4) , 819-836
Investigation of the clinical potential of scattering foil free electron beams
Electron beam therapy has been an important radiation therapy modality for many decades. Studies have been conducted recently for more efficient and advanced delivery of electron beam radiation therapy. X-ray contamination is a common problem that exists with all of the advanced electron beam therapy techniques such as Bolus Electron conformal therapy, segmented electron conformal therapy, and modulated electron arc therapy. X-ray contamination could add some limitations to the advancement and clinical utility of those electron modalities. It was previously shown in the literature that the scattering foil is one of the major accelerator parts contributing to the generation of bremsstrahlung photons. Thus, in this work we investigate the dosimetric characteristics of scattering foil free (SFF) electron beams and the feasibility of using those beams for breast cancer boosts. The SFF electron beams were modeled and simulated using the Monte Carlo method. CT scans of six previously treated breast patients were used for the treatment plan generation utilizing our in-house Monte Carlo-based treatment planning system. Electron boost plans with conventional beams and the SFF beams were generated, respectively, for all patients. A significant reduction of the photon component was observed with the removal of the primary scattering foil for beam energies higher than 12 MeV. Flatness was greatly affected but the difference in flatness between conventional and SFF beams was much reduced for small cone sizes, which were often used clinically for breast boosts. It was found that the SFF electron beams could deliver high-quality dose distributions as conventional electron beams for boost treatments of the breast with an added advantage of a further reduced dose to the lung and the heart.
- 29 July 2013
- Published by IOP Publishing in Physics in Medicine & Biology
- Vol. 58 (16) , 5653-5672
Feasibility of replacing patient specific cutouts with a computer-controlled electron multileaf collimator
A motorized electron multileaf collimator (eMLC) was developed as an add-on device to the Varian linac for delivery of advanced electron beam therapy. It has previously been shown that electron beams collimated by an eMLC have very similar penumbra to those collimated by applicators and cutouts. Thus, manufacturing patient specific cutouts would no longer be necessary, resulting in the reduction of time taken in the cutout fabrication process. Moreover, cutout construction involves handling of toxic materials and exposure to toxic fumes that are usually generated during the process, while the eMLC will be a pollution-free device. However, undulation of the isodose lines is expected due to the finite size of the eMLC. Hence, the provided planned target volume (PTV) shape will not exactly follow the beam's-eye-view of the PTV, but instead will make a stepped approximation to the PTV shape. This may be a problem when the field edge is close to a critical structure. Therefore, in this study the capability of the eMLC to achieve the same clinical outcome as an applicator/cutout combination was investigated based on real patient computed tomographies (CTs). An in-house Monte Carlo based treatment planning system was used for dose calculation using ten patient CTs. For each patient, two plans were generated; one with electron beams collimated using the applicator/cutout combination; and the other plan with beams collimated by the eMLC. Treatment plan quality was compared for each patient based on dose distribution and dose–volume histogram. In order to determine the optimal position of the leaves, the impact of the different leaf positioning strategies was investigated. All plans with both eMLC and cutouts were generated such that 100% of the target volume receives at least 90% of the prescribed dose. Then the percentage difference in dose between both delivery techniques was calculated for all the cases. The difference in the dose received by 10% of the volume of the target was showing a mean percentage difference of 1.57%±1.65, while the difference in the dose received by 99% of the volume was showing a mean percentage difference of 1.08%±0.78. The mean percentage volume of Lung receiving a percentage dose equal to or greater than 20% of the prescribed dose was found to be 8.55%±7.3 and 8.67%±7 for the eMLC and applicator/cutout combination delivery methods respectively. Results have shown that target coverage and critical structure sparing can be effectively achieved by electron beams collimated with the eMLC. Positioning the eMLC leaves in such a way to avoids shielding any part of the projected treatment volume is most conservative and would be the recommended method to define the actual leaf position for the eMLC defined field. More optimal leaf positions can be achieved in shaping the same treatment field through the interplay of different leaf positioning strategies. We concluded that the eMLC represents an effective time saving and pollution-free device that can completely replace patient specific cutouts.
- 29 July 2013
- Published by IOP Publishing in Physics in Medicine & Biology
- Vol. 58 (16) , 5653-5672
Feasibility of replacing patient specific cutouts with a computer-controlled electron multileaf collimator
A motorized electron multileaf collimator (eMLC) was developed as an add-on device to the Varian linac for delivery of advanced electron beam therapy. It has previously been shown that electron beams collimated by an eMLC have very similar penumbra to those collimated by applicators and cutouts. Thus, manufacturing patient specific cutouts would no longer be necessary, resulting in the reduction of time taken in the cutout fabrication process. Moreover, cutout construction involves handling of toxic materials and exposure to toxic fumes that are usually generated during the process, while the eMLC will be a pollution-free device. However, undulation of the isodose lines is expected due to the finite size of the eMLC. Hence, the provided planned target volume (PTV) shape will not exactly follow the beam's-eye-view of the PTV, but instead will make a stepped approximation to the PTV shape. This may be a problem when the field edge is close to a critical structure. Therefore, in this study the capability of the eMLC to achieve the same clinical outcome as an applicator/cutout combination was investigated based on real patient computed tomographies (CTs). An in-house Monte Carlo based treatment planning system was used for dose calculation using ten patient CTs. For each patient, two plans were generated; one with electron beams collimated using the applicator/cutout combination; and the other plan with beams collimated by the eMLC. Treatment plan quality was compared for each patient based on dose distribution and dose–volume histogram. In order to determine the optimal position of the leaves, the impact of the different leaf positioning strategies was investigated. All plans with both eMLC and cutouts were generated such that 100% of the target volume receives at least 90% of the prescribed dose. Then the percentage difference in dose between both delivery techniques was calculated for all the cases. The difference in the dose received by 10% of the volume of the target was showing a mean percentage difference of 1.57%±1.65, while the difference in the dose received by 99% of the volume was showing a mean percentage difference of 1.08%±0.78. The mean percentage volume of Lung receiving a percentage dose equal to or greater than 20% of the prescribed dose was found to be 8.55%±7.3 and 8.67%±7 for the eMLC and applicator/cutout combination delivery methods respectively. Results have shown that target coverage and critical structure sparing can be effectively achieved by electron beams collimated with the eMLC. Positioning the eMLC leaves in such a way to avoids shielding any part of the projected treatment volume is most conservative and would be the recommended method to define the actual leaf position for the eMLC defined field. More optimal leaf positions can be achieved in shaping the same treatment field through the interplay of different leaf positioning strategies. We concluded that the eMLC represents an effective time saving and pollution-free device that can completely replace patient specific cutouts.
- 3 October 2008
- Published by IOP Publishing in Physics in Medicine & Biology
- Vol. 53 (21) , 6009-6025
Dosimetric verification of modulated electron radiotherapy delivered using a photon multileaf collimator for intact breasts
Modulated electron radiotherapy (MERT) may potentially be an effective modality for the treatment of shallow tumors, but dose calculation accuracy and delivery efficiency challenges remain. The purpose of this work is to investigate the dose accuracy of MERT delivery using a photon multileaf collimator (pMLC) on a Siemens Primus accelerator. A Monte Carlo (MC)-based inverse treatment planning system was developed for the 3D treatment planning process. Phase space data of 6, 9, 12 and 15 MeV electron beams were commissioned and used as the input source for MC dose calculations. A treatment plan was performed based on the 3D CT data of a heterogeneous 'breast phantom' that mimics a breast cancer patient, and delivered with 22 segments, each associated with a particular energy and Monitor Unit value. Film and ion chamber dosimetry was carefully performed for the conversion from measurement reading to dose, and the results were employed for plan verification using the heterogeneous breast phantom and a solid water phantom. Dose comparisons between measurements and calculations showed agreement within 2% or 1 mm. We conclude that our in-house MC treatment planning system is capable of performing treatment planning and accurate dose calculations for MERT using the pMLC to deliver radiation therapy to the intact breast.
- 3 October 2008
- Published by IOP Publishing in Physics in Medicine & Biology
- Vol. 53 (21) , 6009-6025
Dosimetric verification of modulated electron radiotherapy delivered using a photon multileaf collimator for intact breasts
Modulated electron radiotherapy (MERT) may potentially be an effective modality for the treatment of shallow tumors, but dose calculation accuracy and delivery efficiency challenges remain. The purpose of this work is to investigate the dose accuracy of MERT delivery using a photon multileaf collimator (pMLC) on a Siemens Primus accelerator. A Monte Carlo (MC)-based inverse treatment planning system was developed for the 3D treatment planning process. Phase space data of 6, 9, 12 and 15 MeV electron beams were commissioned and used as the input source for MC dose calculations. A treatment plan was performed based on the 3D CT data of a heterogeneous 'breast phantom' that mimics a breast cancer patient, and delivered with 22 segments, each associated with a particular energy and Monitor Unit value. Film and ion chamber dosimetry was carefully performed for the conversion from measurement reading to dose, and the results were employed for plan verification using the heterogeneous breast phantom and a solid water phantom. Dose comparisons between measurements and calculations showed agreement within 2% or 1 mm. We conclude that our in-house MC treatment planning system is capable of performing treatment planning and accurate dose calculations for MERT using the pMLC to deliver radiation therapy to the intact breast.